Wildon Farwell
CIK 1847941 · Chief Medical Officer · last filed 2024-08-20
Wildon Farwell is a Chief Medical Officer who has filed 20 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $104.7K of DYN on Aug 20, 2024. Across all open-market trades the lifetime net is −$955.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.61M
1
20
-$955.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Medical Officer | 143,483 | $18.19 | $2.61M | -$955.5K | 20 | 2024-08-20 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-20 | DYN | Sell (S) | −2,321 | -$104.7K | EDGAR |
| 2024-06-11 | DYN | Sell (S) | −2,636 | -$82.4K | EDGAR |
| 2024-05-17 | DYN | Sell (S) | −2,381 | -$67.3K | EDGAR |
| 2024-03-12 | DYN | Sell (S) | −2,615 | -$67.1K | EDGAR |
| 2024-03-11 | DYN | Sell (S) | −9,921 | -$256.6K | EDGAR |
| 2024-02-28 | DYN | Sell (S) | −407 | -$10.2K | EDGAR |
| 2024-02-14 | DYN | Sell (S) | −5,493 | -$137.7K | EDGAR |
| 2024-01-26 | DYN | Sell (S) | −100 | -$2.5K | EDGAR |
| 2023-12-12 | DYN | Sell (S) | −2,666 | -$28.4K | EDGAR |
| 2023-11-16 | DYN | Grant (A) | +82,512 | $0 | EDGAR |